Skip Navigation

European Heart Journal 2002 23(5):376-383; doi:10.1053/euhj.2001.2805
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (72)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Skoog, T.
Right arrow Articles by Hamsten, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skoog, T.
Right arrow Articles by Hamsten, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Plasma tumour necrosis factor-{alpha} and early carotid atherosclerosis in healthy middle-aged men

T. Skooga,f1, W. Dichtlb, S. Boquista,c, C. Skoglund-Anderssona, F. Karpea, R. Tangd, M.G. Bondd, U. de Fairee,f, J. Nilssonb, P. Erikssona and A. Hamstena,c

a The Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Hospital, Stockholm, Sweden
c The Department of Cardiology, Karolinska Hospital, Stockholm, Sweden
e The Cardiovascular Laboratory, the Department of Medicine, Karolinska Hospital, Stockholm, Sweden
f The Institute of Environmental Medicine, Division of Cardiovascular Epidemiology, Karolinska Institute, Stockholm, Sweden
b The Wallenberg Laboratory, Department of Medicine, University of Lund, Malmö University Hospital, Malmö, Sweden
d Division of Ultrasound Research, Wake Forest University School of Medicine, Winston-Salem, NC, U.S.A.

revised May 1, 2001; accepted June 1, 2001

Abstract

Aims Tumour necrosis factor-{alpha} (TNF-{alpha}) is a proinflammatory cytokine, which is implicated in some metabolic disorders and may play a role in the development of cardiovascular disease. We examined whether plasma TNF-{alpha} is related to established cardiovascular risk indicators, plasma levels of soluble cellular adhesion molecules and carotid artery intima–media thickness determined by ultrasound examination in a population-based cohort of 96 healthy 50-year-old men.

Methods and Results TNF-{alpha} and cellular adhesion molecules were measured with enzyme-linked immunosorbent assays. Plasma TNF-{alpha} concentration was associated with systolic and diastolic blood pressure, degrees of alimentary lipaemia, plasma very low density lipoprotein triglyceride, low density lipoprotein (LDL) cholesterol concentrations and peak LDL particle size. Two indices of insulin resistance as well as all soluble cellular adhesion molecules correlated positively with TNF-{alpha}. The plasma TNF-{alpha} concentration was associated with common carotid intima–media thickness in univariate analysis. In contrast, soluble E-selectin and postprandial triglycerides, but not TNF-{alpha}, were independent determinants of common carotid intima–media thickness.

Conclusion The plasma TNF-{alpha} concentration is associated with degrees of early atherosclerosis and correlates with metabolic and cellular perturbations that are considered important for the vascular process.

Key Words: Atherosclerosis, common carotid intima–media thickness, tumour necrosis factor-{alpha}, intercellular adhesion molecule-1, vascular adhesion molecule-1, E-selectin

f1 Correspondence: Tiina Skoog MSc, King Gustaf V Research Institute, Karolinska Hospital, S-171 76 Stockholm, Sweden.

References

  1. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992;10:411–452[CrossRef][ISI][Medline]
  2. Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med. 1995;43:227–235[ISI][Medline]
  3. Beutler B, Cerami A. The biology of cachectin/TNF—a primary mediator of the host response. Annu Rev Immunol. 1989;7:625–655[ISI][Medline]
  4. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91[Abstract/Free Full Text]
  5. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes. 1994;43:1271–1278[Abstract]
  6. Jovinge S, Hamsten A, Tornvall P. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism. 1998;47:113–118[CrossRef][ISI][Medline]
  7. Libby P, Ridker PM. Novel inflammatory markers of coronary risk: theory versus practice. Circulation. 1999;100:1148–1150[Free Full Text]
  8. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251:788–791[Abstract/Free Full Text]
  9. Hwang SJ, Ballantyne CM, Sharrett AR. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997;96:4219–4225[Abstract/Free Full Text]
  10. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998;351:88–92[CrossRef][ISI][Medline]
  11. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol. 1992;140:665–673[Abstract]
  12. Printseva O, Peclo MM, Gown AM. Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol. 1992;140:889–896[Abstract]
  13. van der Wal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol. 1992;141:1427–1433[Abstract]
  14. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation. 1996;93:672–682[Abstract/Free Full Text]
  15. De Caterina R, Basta G, Lazzerini G. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:2646–2654[Abstract/Free Full Text]
  16. Rohde LE, Lee RT, Rivero J. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 1998;18:1765–1770[Abstract/Free Full Text]
  17. Otsuki M, Hashimoto K, Morimoto Y, Kishimoto T, Kasayama S. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes. 1997;46:2096–2101[Abstract]
  18. Peter K, Nawroth P, Conradt C. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol. 1997;17:505–512[Abstract/Free Full Text]
  19. Boquist S, Ruotolo G, Tang R. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima–media thickness in healthy, middle-aged men. Circulation. 1999;100:723–728[Abstract/Free Full Text]
  20. Carlson K. Lipoprotein fractionation. J Clin Pathol. 1973;5:32–37
  21. Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest. 1993;91:748–758[ISI][Medline]
  22. Karpe F, Hamsten A. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res. 1994;35:1311–1317[Abstract]
  23. Skoglund-Andersson C, Tang R, Bond MG, de Faire U, Hamsten A, Karpe F. LDL particle size distribution is associated with carotid intima–media thickness in healthy 50-year-old men. Arterioscler Thromb Vasc Biol. 1999;19:2422–2430[Abstract/Free Full Text]
  24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419[CrossRef][ISI][Medline]
  25. Mercuri M, Tang R, Phillips RM, Bond MG. Ultrasound protocol and quality control procedures in the European Lacidipine Study on Atherosclerosis (ELSA). Blood Press Suppl. 1996;4:20–23[Medline]
  26. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000;101:2149–2153[Abstract/Free Full Text]
  27. Skoog T, van 't Hooft FM, Kallin B. A common functional polymorphism (C->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet. 1999;8:1443–1449[Abstract/Free Full Text]
  28. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126[Free Full Text]
  29. Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev. 1999;10:27–39[CrossRef][ISI][Medline]
  30. Feingold KR, Grunfeld C. Tumour necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest. 1987;80:184–190[ISI][Medline]
  31. Raina N, Matsui J, Cunnane SC, Jeejeebhoy KN. Effect of tumor necrosis factor-alpha on triglyceride and phospholipid content and fatty acid composition of liver and carcass in rats. Lipids. 1995;30:713–718[ISI][Medline]
  32. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95:2409–2415[ISI][Medline]
  33. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem. 1995;270:23780–23784[Abstract/Free Full Text]
  34. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271:665–668[Abstract]
  35. Stephens JM, Pekala PH. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem. 1991;266:21839–21845[Abstract/Free Full Text]
  36. Kahaleh MB, Fan PS. Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol. 1997;15:163–167[ISI][Medline]
  37. Brasier AR, Li J, Wimbish KA. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension. 1996;27:1009–1017[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. Xanthoulea, M. J.J. Gijbels, I. van der Made, H. Mujcic, M. Thelen, M. N. Vergouwe, M. H.C. Ambagts, M. H. Hofker, and M. P.J. de Winther
p55 Tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice
Cardiovasc Res, August 5, 2008; (2008) cvn193v2.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
B. Qin, R. A. Anderson, and K. Adeli
Tumor necrosis factor-{alpha} directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling
Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1120 - G1129.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Marfella, C. Di Filippo, M. Portoghese, F. Ferraraccio, B. Crescenzi, M. Siniscalchi, M. Barbieri, C. Bologna, M. R. Rizzo, F. Rossi, et al.
Proteasome Activity as a Target of Hormone Replacement Therapy-Dependent Plaque Stabilization in Postmenopausal Women
Hypertension, April 1, 2008; 51(4): 1135 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Erridge, T. Attina, C. M Spickett, and D. J Webb
A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation
Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1286 - 1292.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C. Popa, F. H J van den Hoogen, T. R D J Radstake, M. G Netea, A. E Eijsbouts, M. d. Heijer, J. W M van der Meer, P. L C M van Riel, A. F H Stalenhoef, and P. Barrera
Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis
Ann Rheum Dis, November 1, 2007; 66(11): 1503 - 1507.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Rajesh, P. Mukhopadhyay, S. Batkai, G. Hasko, L. Liaudet, J. W. Huffman, A. Csiszar, Z. Ungvari, K. Mackie, S. Chatterjee, et al.
CB2-receptor stimulation attenuates TNF-{alpha}-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2210 - H2218.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
F. Del Porto, B. Lagana, S. Lai, I. Nofroni, F. Tinti, M. Vitale, E. Podesta, A. P. Mitterhofer, and R. D'Amelio
Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis
Rheumatology, July 1, 2007; 46(7): 1111 - 1115.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Popa, M. G. Netea, P. L. C. M. van Riel, J. W. M. van der Meer, and A. F. H. Stalenhoef
The role of TNF-{alpha} in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk
J. Lipid Res., April 1, 2007; 48(4): 751 - 762.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. Zhao, T. D Etherton, K. R Martin, P. J Gillies, S. G West, and P. M Kris-Etherton
Dietary {alpha}-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects
Am. J. Clinical Nutrition, February 1, 2007; 85(2): 385 - 391.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
E. A. G. REIS, M. G. REIS, R. DE CASSIA R. SILVA, T. M. A. CARMO, A. M. O. ASSIS, M. L. BARRETO, I. M. PARRAGA, M. L. P. SANTANA, and R. E. BLANTON
BIOCHEMICAL AND IMMUNOLOGIC PREDICTORS OF EFFICACY OF TREATMENT OR REINFECTION RISK FOR SCHISTOSOMA MANSONI
Am J Trop Med Hyg, November 1, 2006; 75(5): 904 - 909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Ryan, C. T. Taylor, and W. T. McNicholas
Predictors of Elevated Nuclear Factor-{kappa}B-dependent Genes in Obstructive Sleep Apnea Syndrome
Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 824 - 830.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev, April 1, 2006; 86(2): 515 - 581.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Nasir, E. Guallar, A. Navas-Acien, M. H. Criqui, and J. A.C. Lima
Relationship of Monocyte Count and Peripheral Arterial Disease: Results From the National Health and Nutrition Examination Survey 1999-2002
Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1966 - 1971.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Y Stokes and D. N. Granger
The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia?
J. Physiol., February 1, 2005; 562(3): 647 - 653.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. Minoguchi, T. Tazaki, T. Yokoe, H. Minoguchi, Y. Watanabe, M. Yamamoto, and M. Adachi
Elevated Production of Tumor Necrosis Factor-{alpha} by Monocytes in Patients With Obstructive Sleep Apnea Syndrome
Chest, November 1, 2004; 126(5): 1473 - 1479.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
K.J. Joshipura, H.C. Wand, A.T. Merchant, and E.B. Rimm
Periodontal Disease and Biomarkers Related to Cardiovascular Disease
J. Dent. Res., February 1, 2004; 83(2): 151 - 155.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
L S Rallidis, M G Zolindaki, P C Pentzeridis, K P Poulopoulos, A H Velissaridou, and T S Apostolou
Raised concentrations of macrophage colony stimulating factor in severe unstable angina beyond the acute phase are strongly predictive of long term outcome
Heart, January 1, 2004; 90(1): 25 - 29.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. D. Sesso, J. E. Buring, N. Rifai, G. J. Blake, J. M. Gaziano, and P. M. Ridker
C-Reactive Protein and the Risk of Developing Hypertension
JAMA, December 10, 2003; 290(22): 2945 - 2951.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Cesari, B. W.J.H. Penninx, A. B. Newman, S. B. Kritchevsky, B. J. Nicklas, K. Sutton-Tyrrell, S. M. Rubin, J. Ding, E. M. Simonsick, T. B. Harris, et al.
Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study
Circulation, November 11, 2003; 108(19): 2317 - 2322.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. P. Miller, Y.-F. Chen, D. Xing, W. Feng, and S. Oparil
Hormone Replacement Therapy and Inflammation: Interactions in Cardiovascular Disease
Hypertension, October 1, 2003; 42(4): 657 - 663.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Haider, I. Lee, J. Grabarek, Z. Darzynkiewicz, and N. R. Ferreri
Dual Functionality of Cyclooxygenase-2 as a Regulator of Tumor Necrosis Factor-Mediated G1 Shortening and Nitric Oxide-Mediated Inhibition of Vascular Smooth Muscle Cell Proliferation
Circulation, August 26, 2003; 108(8): 1015 - 1021.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. W. Saeed, T. Peng, and C. N. Metz
Ascorbic Acid Blocks the Growth Inhibitory Effect of Tumor Necrosis Factor-{alpha} on Endothelial Cells
Experimental Biology and Medicine, July 1, 2003; 228(7): 855 - 865.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
E Svenungsson, G-Z Fei, K Jensen-Urstad, U de Faire, A Hamsten, and J Frostegard
TNF-{alpha}: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease
Lupus, June 1, 2003; 12(6): 454 - 461.
[Abstract] [PDF]


Home page
J. Nutr.Home page
H. Bruunsgaard, H. E. Poulsen, B. K. Pedersen, K. Nyyssonen, J. Kaikkonen, and J. T. Salonen
Long-Term Combined Supplementations with {alpha}-Tocopherol and Vitamin C Have No Detectable Anti-Inflammatory Effects in Healthy Men
J. Nutr., April 1, 2003; 133(4): 1170 - 1173.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. B. Twickler, G. M. Dallinga-Thie, F. L. J. Visseren, W. R. de Vries, D. W. Erkelens, and H. P. F. Koppeschaar
Induction of Postprandial Inflammatory Response in Adult Onset Growth Hormone Deficiency Is Related to Plasma Remnant-Like Particle-Cholesterol Concentration
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1228 - 1233.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Hurlimann, A. Forster, G. Noll, F. Enseleit, R. Chenevard, O. Distler, M. Bechir, L. E. Spieker, M. Neidhart, B. A. Michel, et al.
Anti-Tumor Necrosis Factor-{alpha} Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis
Circulation, October 22, 2002; 106(17): 2184 - 2187.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G.J. Blake and P.M. Ridker
Tumour necrosis factor-{alpha}, inflammatory biomarkers, and atherogenesis
Eur. Heart J., March 1, 2002; 23(5): 345 - 347.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (72)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Skoog, T.
Right arrow Articles by Hamsten, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skoog, T.
Right arrow Articles by Hamsten, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?